TECLISTAMAB
UNII 54534MX6Z9

Substance Identification & Data

This profile provides standardized clinical and technical data for Teclistamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 54534MX6Z9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2119595-80-9 and the RxNorm Concept ID (RxCUI) 2619426. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

54534MX6Z9

CAS Registry Number

2119595-80-9

RxNorm Concept ID

2619426

Detailed Substance Profile

Preferred Name

TECLISTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

54534MX6Z9

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C136823

National Cancer Institute reference terminology for clinical and research data.

INN ID

10928

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-142

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Teclistamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TECLISTAMAB

TECLISTAMAB-CQYV

Common Names & Synonyms

IMMUNOGLOBULIN G4 (233-PROLINE, 239-ALANINE, 240-ALANINE, 410-LEUCINE), ANTI- (HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL JNJ-63483043 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JNJ-63483043 .LAMBDA.-CHAIN,(231->227'),(234->230')- BIS(DISULFIDE) WITH IMMUNOGLOBULIN G4 (229-PROLINE, 235-ALANINE, 236-ALANINE, 410-ARGININE) ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN MONOCLONALJNJ-63705473 .GAMMA.4-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL JNJ-63705473 .LAMBDA.-CHAIN

IMMUNOGLOBULIN G4-LAMBDA, ANTI-(HOMO SAPIENS TNFRSF17 (TNF RECEPTOR SUPERFAMILY MEMBER 17, TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, BCM, TNFRSF13A, CD269)) AND ANTI-(HOMO SAPIENS CD3 EPSILON (CD3E, LEU-4)), MONOCLONAL ANTIBODY, BISPECIFIC; GAMMA4 HEAVY CHAIN ANTI-TNFRSF17 (1-448) (VH (HOMO SAPIENS IGHV4-39*01 (97.0%) -(IGHD) -IGHJ4*01 (100%)) (10.7.13) (1-121) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, G4V5 H P10, G4V4 CH2 A1.3, A1.2 (CH1 (122-219), HINGE S10>P (229) (220-231), CH2 L92 (310), F1.3>A (235), L1.2>A (236) (232-341), CH3 (342-446), CHS (447-448)) (122-448)), (135-213')-DISULFIDE WITH LAMBDA LIGHT CHAIN ANTI-TNFRSF17 (1'-214') (V-LAMBDA (HOMO SAPIENS IGLV3-21*02 (96.9%) -IGLJ2*01 (100.0%)) (6.3.11) (1'-108') -HOMO SAPIENS IGLC2*01 (99.1%) A43>G (152) (109'-214'))

TECLISTAMAB [INN]

TECLISTAMAB [USAN]

TECLISTAMAB [WHO-DD]

TECLISTAMAB CQYV [WHO-DD]